1. Home
  2. BCDA vs IVDA Comparison

BCDA vs IVDA Comparison

Compare BCDA & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.27

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

HOLD

Current Price

$0.88

Market Cap

5.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
IVDA
Founded
N/A
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
5.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCDA
IVDA
Price
$1.27
$0.88
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
67.0K
704.2K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,395,926.00
Revenue This Year
N/A
$340.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.56
52 Week Low
$1.00
$0.61
52 Week High
$3.20
$8.05

Technical Indicators

Market Signals
Indicator
BCDA
IVDA
Relative Strength Index (RSI) 40.79 43.18
Support Level $1.23 $0.84
Resistance Level $1.34 $1.04
Average True Range (ATR) 0.08 0.09
MACD -0.01 -0.02
Stochastic Oscillator 13.46 11.81

Price Performance

Historical Comparison
BCDA
IVDA

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

Share on Social Networks: